The goal of this retrospective cohort study is to investigate the effects of compound amino acid capsule on nutrition, calcium and phosphorus metabolism in maintenance hemodialysis(MHD) patients. The main questions it aims to answer are: 1. Can compound amino acid capsule improve the nutritional status of MHD patients? 2. Can compound amino acid capsule help to correct the calcium and phosphorus metabolism imbalance of MHD patients? 3. Is compound amino acid capsule safe for MHD patients? We will collect the medical history and laboratory data of MHD patients who regularly took compound amino acid capsule for 9 months or did not use the same preparation in previous medical experience. We focus on the difference of serum albumin level between the treatment group and the control group within 9 months, as well as prealbumin, hemoglobin, ferritin, calcium, phosphorus, 1,25-OH 2-D3 and intact parathyroid hormone (iPTH).
Study Type
OBSERVATIONAL
Enrollment
40
Change from Baseline Serum Albumin at 3 months
Change from baseline serum albumin at 3 months of the treatment group and control group are compared.
Time frame: Data of both groups at baseline and 3 months are collected and analyzed.
Change from Baseline Serum Albumin at 6 months
Change from baseline serum albumin at 6 months of the treatment group and control group are compared.
Time frame: Data of both groups at baseline and 6 months are collected and analyzed.
Change from Baseline Serum Albumin at 9 months
Change from baseline serum albumin at 9 months of the treatment group and control group are compared.
Time frame: Data of both groups at baseline and 9 months are collected and analyzed.
Change from Baseline Prealbumin at 3 months of the treatment group
Within the treatment group, prealbumin at 3 months is compared to baseline. In other words, change from baseline prealbumin at 3 months is compared to 0.
Time frame: Data of the treatment group at baseline and 3 months are collected and analyzed.
Change from Baseline Prealbumin at 3 months of the control group
Within the control group, prealbumin at 3 months is compared to baseline. In other words, change from baseline prealbumin at 3 months is compared to 0.
Time frame: Data of the control group at baseline and 3 months are collected and analyzed.
Change from Baseline Prealbumin at 6 months of the treatment group
Within the treatment group, prealbumin at 6 months is compared to baseline. In other words, change from baseline prealbumin at 6 months is compared to 0.
Time frame: Data of the treatment group at baseline and 6 months are collected and analyzed.
Change from Baseline Prealbumin at 6 months of the control group
Within the control group, prealbumin at 6 months is compared to baseline. In other words, change from baseline prealbumin at 6 months is compared to 0.
Time frame: Data of the control group at baseline and 6 months are collected and analyzed.
Change from Baseline Prealbumin at 9 months of the treatment group
Within the treatment group, prealbumin at 9 months is compared to baseline. In other words, change from baseline prealbumin at 9 months is compared to 0.
Time frame: Data of the treatment group at baseline and 9 months are collected and analyzed.
Change from Baseline Prealbumin at 9 months of the control group
Within the control group, prealbumin at 9 months is compared to baseline. In other words, change from baseline prealbumin at 9 months is compared to 0.
Time frame: Data of the control group at baseline and 9 months are collected and analyzed.
Change from Baseline Hemoglobin at 3 months of the treatment group
Within the treatment group, hemoglobin at 3 months is compared to baseline. In other words, change from baseline hemoglobin at 3 months is compared to 0.
Time frame: Data of the treatment group at baseline and 3 months are collected and analyzed.
Change from Baseline Hemoglobin at 3 months of the control group
Within the control group, hemoglobin at 3 months is compared to baseline. In other words, change from baseline hemoglobin at 3 months compared to 0.
Time frame: Data of the control group at baseline and 3 months are collected and analyzed.
Change from Baseline Hemoglobin at 6 months of the treatment group
Within the treatment group, hemoglobin at 6 months is compared to baseline. In other words, change from baseline hemoglobin at 6 months is compared to 0.
Time frame: Data of the treatment group at baseline and 6 months are collected and analyzed.
Change from Baseline Hemoglobin at 6 months of the control group
Within the control group, hemoglobin at 6 months is compared to baseline. In other words, change from baseline hemoglobin at 6 months is compared to 0.
Time frame: Data of the control group at baseline and 6 months are collected and analyzed.
Change from Baseline Hemoglobin at 9 months of the treatment group
Within the treatment group, hemoglobin at 9 months is compared to baseline. In other words, change from baseline hemoglobin at 9 months is compared to 0.
Time frame: Data of the treatment group at baseline and 9 months are collected and analyzed.
Change from Baseline Hemoglobin at 9 months of the control group
Within the control group, hemoglobin at 9 months is compared to baseline. In other words, change from baseline hemoglobin at 9 months is compared to 0.
Time frame: Data of the control group at baseline and 9 months are collected and analyzed.
Change from Baseline Ferritin at 3 months of the treatment group
Within the treatment group, ferritin at 3 months is compared to baseline. In other words, change from baseline ferritin at 3 months is compared to 0.
Time frame: Data of the treatment group at baseline and 3 months are collected and analyzed.
Change from Baseline Ferritin at 3 months of the control group
Within the control group, ferritin at 3 months is compared to baseline. In other words, change from baseline ferritin at 3 months is compared to 0.
Time frame: Data of the control group at baseline and 3 months are collected and analyzed.
Change from Baseline Ferritin at 6 months of the treatment group
Within the treatment group, ferritin at 6 months is compared to baseline. In other words, change from baseline ferritin at 6 months is compared to 0.
Time frame: Data of the treatment group at baseline and 6 months are collected and analyzed.
Change from Baseline Ferritin at 6 months of the control group
Within the control group, ferritin at 6 months is compared to baseline. In other words, change from baseline ferritin at 6 months is compared to 0.
Time frame: Data of the control group at baseline and 6 months are collected and analyzed.
Change from Baseline Ferritin at 9 months of the treatment group
Within the treatment group, ferritin at 9 months is compared to baseline. In other words, change from baseline ferritin at 9 months is compared to 0.
Time frame: Data of the treatment group at baseline and 9 months are collected and analyzed.
Change from Baseline Ferritin at 9 months of the control group
Within the control group, ferritin at 9 months is compared to baseline. In other words, change from baseline ferritin at 9 months is compared to 0.
Time frame: Data of the control group at baseline and 9 months are collected and analyzed.
Change from Baseline Calcium at 3 months of the treatment group
Within the treatment group, calcium at 3 months is compared to baseline. In other words, change from baseline calcium at 3 months is compared to 0.
Time frame: Data of the treatment group at baseline and 3 months are collected and analyzed.
Change from Baseline Calcium at 3 months of the control group
Within the control group, calcium at 3 months is compared to baseline. In other words, change from baseline calcium at 3 months is compared to 0.
Time frame: Data of the control group at baseline and 3 months are collected and analyzed.
Change from Baseline Calcium at 6 months of the treatment group
Within the treatment group, calcium at 6 months is compared to baseline. In other words, change from baseline calcium at 6 months is compared to 0.
Time frame: Data of the treatment group at baseline and 6 months are collected and analyzed.
Change from Baseline Calcium at 6 months of the control group
Within the control group, calcium at 6 months is compared to baseline. In other words, change from baseline calcium at 6 months is compared to 0.
Time frame: Data of the control group at baseline and 6 months are collected and analyzed.
Change from Baseline Calcium at 9 months of the treatment group
Within the treatment group, calcium at 9 months is compared to baseline. In other words, change from baseline calcium at 9 months is compared to 0.
Time frame: Data of the treatment group at baseline and 9 months are collected and analyzed.
Change from Baseline Calcium at 9 months of the control group
Within the control group, calcium at 9 months is compared to baseline. In other words, change from baseline calcium at 9 months is compared to 0.
Time frame: Data of the control group at baseline and 9 months are collected and analyzed.
Change from Baseline Phosphorus at 3 months of the treatment group
Within the treatment group, phosphorus at 3 months is compared to baseline. In other words, change from baseline phosphorus at 3 months is compared to 0.
Time frame: Data of the treatment group at baseline and 3 months are collected and analyzed.
Change from Baseline Phosphorus at 3 months of the control group
Within the control group, phosphorus at 3 months is compared to baseline. In other words, change from baseline phosphorus at 3 months is compared to 0.
Time frame: Data of the control group at baseline and 3 months are collected and analyzed.
Change from Baseline Phosphorus at 6 months of the treatment group
Within the treatment group, phosphorus at 6 months is compared to baseline. In other words, change from baseline phosphorus at 6 months is compared to 0.
Time frame: Data of the treatment group at baseline and 6 months are collected and analyzed.
Change from Baseline Phosphorus at 6 months of the control group
Within the control group, phosphorus at 6 months is compared to baseline. In other words, change from baseline phosphorus at 6 months is compared to 0.
Time frame: Data of the control group at baseline and 6 months are collected and analyzed.
Change from Baseline Phosphorus at 9 months of the treatment group
Within the treatment group, phosphorus at 9 months is compared to baseline. In other words, change from baseline phosphorus at 9 months is compared to 0.
Time frame: Data of the treatment group at baseline and 9 months are collected and analyzed.
Change from Baseline Phosphorus at 9 months of the control group
Within the control group, phosphorus at 9 months is compared to baseline. In other words, change from baseline phosphorus at 9th month is compared to 0.
Time frame: Data of the control group at baseline and 9 months are collected and analyzed.
Change from Baseline 1,25-(OH) 2-D3 at 3 months of the treatment group
Within the treatment group, 1,25-(OH) 2-D3 at 3 months is compared to baseline. In other words, change from baseline 1,25-(OH) 2-D3 at 3 months is compared to 0.
Time frame: Data of the treatment group at baseline and 3 months are collected and analyzed.
Change from Baseline 1,25-(OH) 2-D3 at 3 months of the control group
Within the control group, 1,25-(OH) 2-D3 at 3 months is compared to baseline. In other words, change from baseline 1,25-(OH) 2-D3 at 3 months is compared to 0.
Time frame: Data of the control group at baseline and 3 months are collected and analyzed.
Change from Baseline 1,25-(OH) 2-D3 at 6 months of the treatment group
Within the treatment group, 1,25-(OH) 2-D3 at 6 months is compared to baseline. In other words, change from baseline 1,25-(OH) 2-D3 at 6 months is compared to 0.
Time frame: Data of the treatment group at baseline and 6 months are collected and analyzed.
Change from Baseline 1,25-(OH) 2-D3 at 6 months of the control group
Within the control group, 1,25-(OH) 2-D3 at 6 months is compared to baseline. In other words, change from baseline 1,25-(OH) 2-D3 at 6 months is compared to 0.
Time frame: Data of the control group at baseline and 6 months are collected and analyzed.
Change from Baseline 1,25-(OH) 2-D3 at 9 months of the treatment group
Within the treatment group, 1,25-(OH) 2-D3 at 9 months is compared to baseline. In other words, change from baseline 1,25-(OH) 2-D3 at 9 months is compared to 0.
Time frame: Data of the treatment group at baseline and 9 months are collected and analyzed.
Change from Baseline 1,25-(OH) 2-D3 at 9 months of the control group
Within the control group, 1,25-(OH) 2-D3 at 9 months is compared to baseline. In other words, change from baseline 1,25-(OH) 2-D3 at 9 months is compared to 0.
Time frame: Data of the control group at baseline and 9 months are collected and analyzed.
Change from Baseline Intact Parathyroid Hormone (iPTH) at 3 months of the treatment group
Within the treatment group, iPTH at 3 months is compared to baseline. In other words, change from baseline iPTH at 3 months is compared to 0.
Time frame: Data of the treatment group at baseline and 3 months are collected and analyzed.
Change from Baseline iPTH at 3 months of the control group
Within the control group, iPTH at 3 months is compared to baseline. In other words, change from baseline iPTH at 3 months is compared to 0.
Time frame: Data of the control group at baseline and 3 months are collected and analyzed.
Change from Baseline iPTH at 6 months of the treatment group
Within the treatment group, iPTH at 6 months is compared to baseline. In other words, change from baseline iPTH at 6 months is compared to 0.
Time frame: Data of the treatment group at baseline and 6 months are collected and analyzed.
Change from Baseline iPTH at 6 months of the control group
Within the control group, iPTH at 6 months is compared to baseline. In other words, change from baseline iPTH at 6 months is compared to 0.
Time frame: Data of the control group at baseline and 6 months are collected and analyzed.
Change from Baseline iPTH at 9 months of the treatment group
Within the treatment group, iPTH at 9 months is compared to baseline. In other words, change from baseline iPTH at 9 months is compared to 0.
Time frame: Data of the treatment group at baseline and 9 months are collected and analyzed.
Change from Baseline iPTH at 9 months of the control group
Within the control group, iPTH at 9 months is compared to baseline. In other words, change from baseline iPTH at 9 months is compared to 0.
Time frame: Data of the control group at baseline and 9 months are collected and analyzed.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.